Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Cresco Labs acquires PharmaCann's dispensaries

PUBLIC · CRLBFSep 02, 2026•6 days ago

Acquiring Company

Cresco Labs

Acquired Company

PharmaCann Penn

ChicagoChicagoAgriculture and FarmingCommunity And LifestyleHealth CareFood And BeverageAlternative MedicineOtherHealthcareAlternative Medicine

Description

Cresco Labs has completed the acquisition of PharmaCann Penn, LLC, acquiring nine operational retail medical marijuana dispensaries in Pennsylvania. The transaction is valued at US$50 million and enhances Cresco's leadership in the state's medical marijuana market. This move strengthens Cresco's market presence and expands its service offerings to patients.

Company Information

Company

Cresco Labs

Location

400 W ERIE ST SUITE 110

Chicago, Illinois, United States

About

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Don't miss Cresco Labs's next move

Get an email the moment Cresco Labs makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Jason Erkes
Likely contact at this company
••••••••@••••••••

See Jason Erkes's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Cresco Labs's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired PharmaCann Penn?

PharmaCann Penn was acquired by Cresco Labs, based in Chicago. The deal was reported on September 2, 2026. Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Cresco Labs is publicly traded (CRLBF) and operates in Agriculture and Farming.

When did Cresco Labs acquire PharmaCann Penn?

Cresco Labs's acquisition of PharmaCann Penn was reported on September 2, 2026. Cresco Labs has completed the acquisition of PharmaCann Penn, LLC, acquiring nine operational retail medical marijuana dispensaries in Pennsylvania. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does PharmaCann Penn do?

PharmaCann Penn is a company that operates retail medical marijuana dispensaries in Pennsylvania. It is part of PharmaCann, which is known for its commitment to providing patients with access to high-quality cannabis products. It is privately held, operating in Other, and is based in Chicago.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.